Sleep ⏱ Half-life: Short plasma half-life (minutes), but sleep-modulating effects persist for hours, suggesting downstream neuromodulatory cascades.

DSIP

Delta Sleep-Inducing Peptide

Buy from $29.99 →
Half-Life
Short plasma half-life (minutes), but sleep-modulating effects persist for hours, suggesting downstream neuromodulatory cascades.
Mol. Weight
848.82 g/mol

What is DSIP?

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide with a unique mechanism — rather than acting as a sedative, it appears to normalize and optimize sleep architecture, particularly promoting the restorative delta (slow-wave) sleep phase.

Research Applications

Sleep architecture research, stress response modulation, cortisol regulation, chronic pain studies, and withdrawal management models.

Dosage Information (Research Use)

Research protocols: 100-300 mcg subcutaneously or IV, typically administered in the evening. Course-based protocols (10-14 days) documented in European clinical research. Research use only.

Reconstitution & Handling

Standard BAC water reconstitution.

Half-Life & Pharmacokinetics

Short plasma half-life (minutes), but sleep-modulating effects persist for hours, suggesting downstream neuromodulatory cascades.

Reported Observations in Literature

Generally well-tolerated. Does not produce next-day sedation or cognitive impairment. No dependence or tolerance reported in available literature.

Key Research References

  • Schoenenberger GA, Monnier M. “Characterization of a delta-electroencephalogram-sleep-inducing peptide.” Proc Natl Acad Sci USA. 1977

How DSIP Works

DSIP is a nine-amino acid neuropeptide first isolated from rabbit brain during electrically-induced sleep studies. Unlike sedative/hypnotic drugs, DSIP does not force sleep — rather, it modulates sleep architecture by promoting delta (slow-wave) sleep patterns. Additional mechanisms include modulation of corticotropin and cortisol levels, LH/GH release normalization, and possible endogenous opioid system interactions.

Research Findings

Research shows improved sleep onset, increased delta wave percentage during sleep, and normalization of disrupted sleep patterns without morning grogginess. Also studied for stress tolerance, alcohol withdrawal support, and chronic pain management in European clinical settings.

Dosage & Administration

Research protocols: 100-300 mcg subcutaneously or IV, typically administered in the evening. Course-based protocols (10-14 days) documented in European clinical research. Research use only.

Safety & Side Effects

Generally well-tolerated. Does not produce next-day sedation or cognitive impairment. No dependence or tolerance reported in available literature.

Important: All safety information is derived from published research, primarily animal studies. No controlled human clinical trial data exists unless explicitly noted. This compound is sold for research purposes only.

Quick Facts

Sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
Molecular Weight 848.82 g/mol
Half-Life Short plasma half-life (minutes), but sleep-modulating effects persist for hours, suggesting downstream neuromodulatory cascades.
Available Sizes 5mg
Storage Lyophilized: -20°C. Reconstituted: 2-8°C.

Key Research References

  • Schoenenberger GA, Monnier M. "Characterization of a delta-electroencephalogram-sleep-inducing peptide." Proc Natl Acad Sci USA. 1977

Get DSIP from SourcePeptides

Third-party tested • Research-grade purity • Fast US shipping

Shop Now →